Agrochemicals company Insecticides (India) announced Q1FY27 results Consolidated Financial Highlights: The company reported Revenue from Operations of Rs 61,152.31 lakh in Q1FY27, representing a YoY decrease of 11.52% from Rs 69,113.31 lakh in Q1FY26 and a QoQ increase of 43.46% from Rs 42,625.96 lakh in Q4FY26. Total Income for Q1FY27 stood at Rs 61,686.70 lakh, compared to Rs 69,483.88 lakh in Q1FY26 (down 11.22% YoY) and Rs 43,099.15 lakh in Q4FY26 (up 43.13% QoQ). Other Income for Q1FY27 was Rs 534.39 lakh, as against Rs 370.57 lakh in Q1FY26 and Rs 473.19 lakh in Q4FY26. Profit Before Tax (PBT) reached Rs 5,882.05 lakh in Q1FY27, a YoY decrease of 24.06% from Rs 7,745.35 lakh and a QoQ increase of 266.12% from Rs 1,606.61 lakh. Net Profit for the period (Profit for the period) was Rs 4,387.44 lakh in Q1FY27, marking a YoY decline of 24.49% from Rs 5,810.54 lakh and a QoQ growth of 274.68% from Rs 1,170.99 lakh in Q4FY26. Total Comprehensive Income for Q1FY27 was Rs 4,227.61 lakh, compared to Rs 5,805.08 lakh in Q1FY26 and Rs 1,411.26 lakh in Q4FY26. Basic and Diluted Earnings Per Share (EPS) for Q1FY27 stood at Rs 15.08, compared to Rs 19.97 in Q1FY26 and Rs 4.02 in Q4FY26. Standalone Financial Highlights: Revenue from Operations for Q1FY27 was Rs 61,648.22 lakh, reflecting a YoY decrease of 10.83% from Rs 69,137.24 lakh and a QoQ increase of 44.05% from Rs 42,795.60 lakh. Total Income for the standalone entity reached Rs 62,110.58 lakh in Q1FY27, as against Rs 69,511.75 lakh in Q1FY26 and Rs 43,275.89 lakh in Q4FY26. Standalone Profit Before Tax for Q1FY27 was Rs 5,626.47 lakh, compared to Rs 7,684.83 lakh in Q1FY26 (down 26.78% YoY) and Rs 1,870.24 lakh in Q4FY26 (up 200.84% QoQ). Standalone Net Profit for Q1FY27 stood at Rs 4,183.05 lakh, showing a YoY decline of 27.00% from Rs 5,730.05 lakh and a QoQ increase of 191.22% from Rs 1,436.37 lakh. Standalone Basic and Diluted EPS for Q1FY27 was Rs 14.38, compared to Rs 19.69 in Q1FY26 and Rs 4.94 in Q4FY26. Business Highlights: Subsidiary Update: The Board of Directors, in its meeting held on August 09, 2024, approved the dissolution/liquidation of its wholly owned subsidiary, IIL Overseas DMCC, Dubai. The dissolution was approved by the Registrar of Companies of Dubai Multi Commodities Centre Authority (DMCCA) vide its letter dated September 19, 2025. Audit Review: The figures for the quarter ended March 31, 2026, are the balancing figures between audited figures for the full financial year ended March 31, 2026, and the unaudited published year-to-date figures up to December 31, 2025. Rajesh Kumar Aggarwal, MD, Insecticides (India), said: We delivered a resilient performance during the quarter despite a subdued demand, supported by our diversified product portfolio, presence across key crops, strong execution capabilities, and clear strategic direction. While deficient rainfall impacted near-term revenue, pricing discipline and operating efficiencies helped maintain stability in gross margin. With an improving macro environment and focused execution, we remain confident of progressively building momentum through the coming quarters. Our confidence is supported by the benefits emerging from sustained investments in premiumization, manufacturing, research, digital transformation, and global partnerships. The continued expansion of our Focus Maharatna and Maharatna portfolios, supported by collaborations with leading global innovators, is strengthening margins, deepening farmer engagement, enhancing the overall quality of growth. Additionally, Kaeros Research is evolving into a significant growth platform and the Company is advancing its international business footprint. Supported by capacity expansion, backward integration, and operational excellence, we are building a more resilient and future-ready organization. We remain committed to delivering sustainable, high-quality growth and creating enduring value for farmers, partners, employees, and shareholders. Result PDF
Agrochemicals company Insecticides (India) announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: Consolidated revenue for Q4FY26 was Rs. 42,625.96 lakh, a QoQ increase of 10.74% from Rs. 38,491.62 lakh and a YoY increase of 18.76% from Rs. 35,892.05 lakh. For the full year FY26, consolidated revenue reached Rs. 2,14,000.98 lakh compared to Rs. 1,99,994.96 lakh in FY25. Total Income: Consolidated total income for FY26 stood at Rs. 2,15,171.86 lakh compared to Rs. 2,00,694.51 lakh in FY25. Profit Before Tax (PBT): For the full year FY26, consolidated PBT was Rs. 18,667.93 lakh compared to Rs. 19,276.99 lakh in FY25. Net Profit: Consolidated net profit for FY26 was Rs. 13,941.10 lakh, compared to Rs. 14,201.86 lakh in FY25. Total Comprehensive Income: For the full year FY26, consolidated total comprehensive income was Rs. 14,163.75 lakh compared to Rs. 14,067.69 lakh in FY25. Standalone Financial Highlights: Revenue from Operations: For Q4FY26, the company reported revenue of Rs. 42,795.60 lakh, representing a QoQ increase of 11.57% compared to Rs. 38,356.38 lakh in Q3FY26 and a YoY increase of 19.16% compared to Rs. 35,914.51 lakh in Q4FY25. For the full year FY26, revenue stood at Rs. 2,14,414.11 lakh compared to Rs. 2,00,226.58 lakh in FY25, a growth of 7.09%. Total Income: Total income for Q4FY26 was Rs. 43,275.89 lakh, up 12.56% QoQ from Rs. 38,445.26 lakh and up 19.52% YoY from Rs. 36,208.05 lakh. For the full year FY26, total income reached Rs. 2,15,625.23 lakh against Rs. 2,00,949.16 lakh in FY25. Profit Before Tax (PBT): The PBT for Q4FY26 stood at Rs. 1,870.24 lakh, showing a QoQ growth of 52.87% over Rs. 1,223.41 lakh in Q3FY26, but a YoY decline of 15.95% compared to Rs. 2,225.13 lakh in Q4FY25. For FY26, PBT was Rs. 18,197.70 lakh compared to Rs. 19,028.49 lakh in FY25. Net Profit: Net profit for Q4FY26 was Rs. 1,436.37 lakh, a QoQ increase of 62.43% from Rs. 884.30 lakh and a YoY increase of 2.42% from Rs. 1,402.49 lakh. For the full year FY26, net profit was Rs. 13,581.74 lakh compared to Rs. 13,976.56 lakh in FY25. Total Comprehensive Income: For the full year FY26, total comprehensive income was Rs. 13,803.30 lakh compared to Rs. 13,848.59 lakh in FY25. Business Highlights: Segment Performance: The company operates in a single business segment, "Agro-Chemicals," which comprises Technical and Formulation activities. New Employee Stock Purchase Scheme: The Board approved the "IIL ESPS Scheme 2026," covering an aggregate number of up to 2,00,000 equity shares of face value Rs. 10 each. The scheme is subject to shareholder approval at the upcoming 29th Annual General Meeting. Board and Management Changes: The Board accepted the resignation of Mrs. Nikunj Aggarwal as Whole Time Director with effect from May 28, 2026. Mr. Sanskar Aggarwal was appointed as Whole Time Director (Additional) for a five-year term effective from May 28, 2026, to May 27, 2031. Mr. Atul Kumar was appointed as Vice President - Sales (North). Subsidiary Liquidation: The company completed the dissolution/liquidation of its wholly owned subsidiary, IIL Overseas DMCC, Dubai, which was approved by the registrar on September 19, 2025. Internal Auditor Appointment: M/s. T Jain & Associates, Chartered Accountants, were appointed as Internal Auditors for a five-year period from April 01, 2026, to March 31, 2031. Annual General Meeting: The 29th AGM is scheduled to be held on Wednesday, August 12, 2026. Commenting on the results and performance, Rajesh Kumar Aggarwal, MD of Insecticides (India). said: “Insecticides (India) Limited delivered a steady performance during the year, supported by healthy growth momentum and stable margins, despite a challenging operating environment marked by erratic rainfall, restricted field activities, and global disruptions. The Company continued to strengthen its innovation-led product portfolio through successful launches in collaboration with leading global partners. Key launches included Altair with Nissan Chemical Corporation and Sparcle & Granuvia with Corteva Agriscience, offering reliable, easy-to-use, and next-generation crop solutions to Indian farmers. To further enhance market reach and distribution depth, we introduced B2C products under Kaeros Research Limited, wholly owned subsidiary of the Company. Going forward, IIL remains focused on strengthening its product pipeline, expanding strategic collaborations, enhancing organizational capabilities, premiumizing its brand equity, deepening dealer and farmer engagement, and driving innovative marketing initiatives/ Amid global uncertainties, the Company remains agile and committed to building a stronger, more resilient, and future-ready organization. Result PDF
Agrochemicals company Insecticides (India) announced Q3FY26 results Revenue: Rs 38,491.62 crore against Rs 35,770.47 crore during Q3FY25, change 8%. PBT: Rs 1,430.26 crore against Rs 2,228.16 crore during Q3FY25, change -36%. PAT: Rs 1,048.82 crore against Rs 1,736.5 crore during Q3FY25, change -40%. EPS: 3.6 for Q3FY26. Result PDF
Agrochemicals company Insecticides (India) announced Q2FY26 results Revenue from Operations: Rs 637.70 crore against Rs 626.64 crore during Q2FY25, change 2%. EBITDA: Rs 89.48 crore against Rs 89.72 crore during Q2FY25. EBITDA Margin: 14.03% for Q2FY26. PAT: Rs 59.11 crore against Rs 61.39 crore during Q2FY25, change -4%. Rajesh Kumar Aggarwal, MD, Insecticides (India) Ltd, said: “Insecticides (India) has delivered a resilient performance in Q2 with sales growth of 2% and sustained profitability, despite challenging weather conditions. The Company proactively expanded sales and distribution efforts to stay closer to farmers, complemented by several new product introductions during H1. Persistent and wide spread rains since mid-July, led to significant crop damage across regions and limited farmers’ access to fields. Consequently, agrochemical consumption remain subdued, accompanied by higher working capital utilization. Our continued focus on innovation, premiumization, and Complete Crop Solutions has helped strengthen our brand saliency and reinforced our market presence. Our collaboration with Corteva Agriscience is a strong step towards bringing global innovations to Indian farmlands. By combining Corteva Agriscience’s advanced technology with Insecticides (India) extensive market reach, we aim to deepen our engagement with farmers through a strong portfolio of premium products. We are also pleased to welcome Mr. Devendra Kumar Ray as Chief Operating Officer of the Company. An industry veteran with over thirty five years of experience in large scale chemical manufacturing and operations management. We continue to remain focused on enhancing operational efficiency and strengthening our organisational capabilities. Both domestic and global market conditions indicate a cohesive growth environment for the industry, underpinned by firmness in raw material prices across key product categories. Looking ahead, we remain optimistic, supported by adequate soil moisture, favourable Rabi sowing prospects, and stable input pricing. With a strong product pipeline, upcoming launches, and deeper farmer engagement, we are well-positioned to drive revenue growth and sustain profit margins. Our commitment to innovation, sustainability, and value creation remains unwavering as we continue to empower India’s farmers and strengthen our leadership in the crop protection and nutrition space." Result PDF
Agrochemicals company Insecticides (India) announced Q1FY26 results Revenue from Operations: Rs 691.13 crore compared to Rs 656.69 crore during Q1FY25, change 5%. EBITDA: Rs 84.59 crore compared to Rs 72.13 crore during Q1FY25, change 17%. EBITDA Margin: 12.2% for Q1FY26. PAT: Rs 58.11 crore compared to Rs 49.37 crore during Q1FY25, change 18%. Rajesh Kumar Aggarwal, MD of Insecticides (India), said: “We are pleased to report a strong start to this season, with diverse offerings of premium products, three new product launches and effective marketing initiatives. Our continued emphasis on premiumization delivered encouraging results, leading to an improvement in profitability wherein PAT grew by 18% in Q1FY26. This performance reflects the effectiveness of our strategic framework, which emphasises sustained margin improvement, a sharper focus on premium products, and a complete crop solution provider. The business environment remained broadly favourable during the quarter. The season commenced with an early onset of the Southwest monsoon, healthy reservoir levels and visible signs of global demand recovery with stable raw material prices. Kharif season started well for certain crops like Rice, Maize, while uneven rain in certain parts impacted the sowing of other crops. We are now considered an innovative crop solution provider, wherein we are seen by the farmers as their reliable partner, engaging early from sowing till harvest. And will provide a leadership position in major crops in India. Another transformative step was IIL Crop Solution Plots. These are model fields cultivated using IIL Crop Solutions for major crops, helping farmers and channel partners to experience the benefits in terms of differences in crop health, yield, and overall productivity. During the quarter, we launched three new products, including Altair a patented pre-emergent herbicide for paddy developed by Nissan Chemical Corporation, Japan—which will be exclusively marketed by us in India. With overwhelming response to the new launches of the last few years, we are well-positioned to capitalise on emerging opportunities. Our Dahej facility has received the necessary approvals and will contribute significantly to our growth requirements and efficient operational management. Looking ahead, we remain optimistic about the season, supported by favourable tailwinds such as a strong monsoon, rising reservoir levels, and expanded crop sowing. Our growth outlook remains strong for premium products, driven by deeper farmer connections and continued expansion of our product portfolio. We are deeply committed to sustainability, innovation, and responsible growth with continued focus on delivering long-term value to our stakeholders while making a positive impact on the environment and the communities we serve. With a strong foundation and a clear strategic vision, we are confident in building a resilient and promising future for our business.” Result PDF